Aera Therapeutics
3 known investors
Aera Therapeutics develops genetic medicines using next-generation delivery technologies and precision payloads optimized for specific diseases. The company focuses on advancing transformative treatments in areas including oncology, rare genetic diseases, and cell therapies.
AI & Machine LearningBiotechDeep TechMedical Devices
Founders & leadership
AA
Akin Akinc, Ph.D.CEO
Investors · 3
In the news
- Series B Funding Has Also Fallen Sharplynews.crunchbase.com · 2023
- Biotech company Aera Therapeutics pulls in $193mventurecapitaljournal.com · 2023
- Aera Therapeutics emerges from stealth mode with $193M to advance gene therapiesmmm-online.com · 2023
- Aera Therapeutics Launches with $193M in Series A and Series B Financingfinsmes.com · 2023
- Start-up aims to advance transformative genetic medicines - Drug Discovery World (DDW)ddw-online.com · 2023
- On hunt for better gene med delivery, Aera exits stealth with $193M and Alnylam vet at helmfiercebiotech.com · 2023